Trial Profile
Clinical Trials Insight: 700054579
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2010
Price :
$35
*
At a glance
- Drugs HE 3235 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Harbor Therapeutics
- 15 Mar 2010 New trial record.